INFECTIOUS COMPLICATIONS FOLLOWING ISOLATED LUNG TRANSPLANTATION

被引:125
作者
MAURER, JR
TULLIS, DE
GROSSMAN, RF
VELLEND, H
WINTON, TL
PATTERSON, GA
机构
[1] UNIV TORONTO,DEPT MED,TORONTO M5S 1A1,ONTARIO,CANADA
[2] UNIV TORONTO,DEPT SURG,TORONTO M5S 1A1,ONTARIO,CANADA
关键词
D O I
10.1378/chest.101.4.1056
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study Objective: To ascertain the incidence, types, morbidity, and mortality of infectious episodes in isolated lung transplant recipients. Design: Retrospective chart review of patients who have undergone transplants over a six-year period in one institution. Patients: Twenty-three single and 17 double lung transplants followed up between 2 and 68 months. Results: Fifty-one episodes of infection occurred in the group with a slight predominance in the double lung transplants. The 32 episodes of bacterial infection constituted the largest group of infection and more than half of these were pneumonias. Organisms identified were predominantly Gram negative. While bacterial processes made up the bulk of infections, fatalities were rare. Viral and fungal infections were less common, but more often fatal. Of six cases of viral pneumonitis, two were fatal; two of five cases of invasive fungal infection were also fatal. Overall, six patients died of infection. Conclusion: Our findings support previous reports from heart-lung centers documenting a high rate of infectious complications, particularly pneumonia, in recipients of lung grafts. In our experience, bacterial infections are the most common (two of three infections), but have the lowest mortality. Efforts should be directed toward establishing effective prophylaxis programs and early detection of infection.
引用
收藏
页码:1056 / 1059
页数:4
相关论文
共 13 条
  • [1] A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS
    BALFOUR, HH
    CHACE, BA
    STAPLETON, JT
    SIMMONS, RL
    FRYD, DS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) : 1381 - 1387
  • [2] INFECTIOUS COMPLICATIONS IN HEART-LUNG TRANSPLANT RECIPIENTS
    BROOKS, RG
    HOFFLIN, JM
    JAMIESON, SW
    STINSON, EB
    REMINGTON, JS
    [J]. AMERICAN JOURNAL OF MEDICINE, 1985, 79 (04) : 412 - 422
  • [3] LUNG IMMUNOGENICITY, REJECTION, AND OBLITERATIVE BRONCHIOLITIS
    BURKE, CM
    GLANVILLE, AR
    THEODORE, J
    ROBIN, ED
    [J]. CHEST, 1987, 92 (03) : 547 - 549
  • [4] CHAN CK, 1990, CLIN CHEST MED, V11, P323
  • [5] DOLOVICH M, 1987, American Review of Respiratory Disease, V135, pA363
  • [6] INFECTIONS IN HEART-LUNG TRANSPLANT RECIPIENTS
    DUMMER, JS
    MONTERO, CG
    GRIFFITH, BP
    HARDESTY, RL
    PARADIS, IL
    HO, M
    [J]. TRANSPLANTATION, 1986, 41 (06) : 725 - 729
  • [7] A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND-STUDY OF TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF INFECTION IN RENAL-TRANSPLANTATION - CLINICAL EFFICACY, ABSORPTION OF TRIMETHOPRIM-SULFAMETHOXAZOLE, EFFECTS ON THE MICROFLORA, AND THE COST-BENEFIT OF PROPHYLAXIS
    FOX, BC
    SOLLINGER, HW
    BELZER, FO
    MAKI, DG
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 89 (03) : 255 - 274
  • [8] HEART-LUNG TRANSPLANTATION - LESSONS LEARNED AND FUTURE HOPES
    GRIFFITH, BP
    HARDESTY, RL
    TRENTO, A
    PARADIS, IL
    DUQUESNOY, RJ
    ZEEVI, A
    DAUBER, JH
    DUMMER, JS
    THOMPSON, ME
    GRYZAN, S
    BAHNSON, HT
    [J]. ANNALS OF THORACIC SURGERY, 1987, 43 (01) : 6 - 16
  • [9] HESSE UJ, 1986, ARCH SURG-CHICAGO, V121, P1056
  • [10] PULMONARY COMPLICATIONS OF BONE-MARROW TRANSPLANTATION
    KROWKA, MJ
    ROSENOW, EC
    HOAGLAND, HC
    [J]. CHEST, 1985, 87 (02) : 237 - 246